Live Breaking News & Updates on Susquehanna Fundamental Investments

Stay updated with breaking news from Susquehanna fundamental investments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Thermon Group Holdings, Inc. (NYSE:THR) SVP Mark John Roberts Sells 2,910 Shares

Thermon Group Holdings, Inc. (NYSE:THR – Get Free Report) SVP Mark John Roberts sold 2,910 shares of Thermon Group stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $33.35, for a total value of $97,048.50. Following the transaction, the senior vice president now owns 50,920 shares of […] ....

Entrypoint , British-columbia , Canada , United-states , America , Roth-mkm , Mark-john-roberts , Thermon-group-price-performance , Hedge-funds-weigh-in-on-thermon-group , Thermon-group-holdings-inc , Susquehanna-fundamental-investments , News-ratings-for-thermon-group-daily

Short Interest in Canaan Inc. (NASDAQ:CAN) Rises By 7.7%

Canaan Inc. (NASDAQ:CAN – Get Free Report) was the recipient of a significant increase in short interest in May. As of May 15th, there was short interest totalling 28,650,000 shares, an increase of 7.7% from the April 30th total of 26,590,000 shares. Based on an average daily volume of 13,290,000 shares, the short-interest ratio is […] ....

Ivyrock-asset-management-hk-ltd , Headlands-technologies , Canaan-inc , Susquehanna-fundamental-investments , Quadrature-capital-ltd , Sg-americas-securities , Nasdaq , Get-free-report , Capital-ltd , Fundamental-investments , Rock-asset-management

Insider Selling: Allogene Therapeutics, Inc. (NASDAQ:ALLO) Director Sells 11,200 Shares of Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) Director Franz B. Humer sold 11,200 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $2.34, for a total value of $26,208.00. Following the completion of the sale, the director now owns 255,253 […] ....

Canada , Franzb-humer , Piper-sandler , Canada-life-assurance , Pricet-rowe-associates-inc , Allogene-therapeutics-company-profile , Nasdaq , Allogene-therapeutics-inc , Susquehanna-fundamental-investments , Jpmorgan-chase-co , Securities-exchange-commission , Headlands-technologies

Rackspace Technology, Inc. (NASDAQ:RXT) Receives Average Rating of "Hold" from Brokerages

Shares of Rackspace Technology, Inc. (NASDAQ:RXT – Get Free Report) have received a consensus rating of “Hold” from the eight research firms that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have issued a buy recommendation […] ....

Canada , Raymond-james , Raymond-james-associates , Tower-research-capital , Rackspace-technology-inc , Analyst-recommendations-for-rackspace-technology , Multicloud-services , Rackspace-technology-stock-performance , Rackspace-technology , Royal-bank , Susquehanna-fundamental-investments , Insider-transactions-at-rackspace-technology

CytomX Therapeutics (NASDAQ:CTMX) Upgraded at Piper Sandler

Piper Sandler upgraded shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) from a neutral rating to an overweight rating in a report published on Tuesday morning, MarketBeat.com reports. Piper Sandler currently has $3.50 price objective on the biotechnology company’s stock, up from their prior price objective of $2.25. A number of other research firms have […] ....

Piper-sandler , Seana-mccarthy , Jpmorgan-chase-co , Congress-park-capital , Alphamark-advisors , Jefferies-financial-group , Acadian-asset-management , Sg-americas-securities , Susquehanna-fundamental-investments , Cytomx-therapeutics-inc , Cytomx-therapeutics-company-profile , Securities-exchange-commission